Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · Real-Time Price · USD
1.935
-0.385 (-16.59%)
Mar 18, 2026, 1:35 PM EDT - Market open

RVPH Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
2261,6862,8761,7388341,614
Market Cap Growth
279.23%-41.36%65.45%108.34%-48.30%182.51%
Enterprise Value
231.031,6732,8521,720804.561,605
Last Close Price
1.9436.20103.0085.0057.80174.80
PE Ratio
--2.01-3.12-2.93-4.98-7.05
PB Ratio
2.462075.10502.84207.0529.08295.24
P/TBV Ratio
1.1173.8421.439.881.494.90
P/FCF Ratio
--50.27-101.52-91.67-78.20-396.82
P/OCF Ratio
--50.27-101.52-91.67-78.20-396.82
EV/EBITDA Ratio
--54.32-72.20-60.91-79.62-659.37
EV/EBIT Ratio
--54.32-72.20-60.91-79.62-659.21
EV/FCF Ratio
--49.88-100.70-90.69-75.41-394.66
Debt / Equity Ratio
-0.560000
Debt / EBITDA Ratio
--0.01----
Debt / FCF Ratio
--0.01----
Net Debt / Equity Ratio
-2.90-16.02-4.09-2.21-1.03-1.60
Net Debt / EBITDA Ratio
0.570.420.590.662.943.60
Net Debt / FCF Ratio
-0.390.830.982.782.15
Quick Ratio
1.350.921.361.8612.666.57
Current Ratio
1.391.011.381.9013.396.57
Return on Equity (ROE)
-848.77%-916.17%-556.38%-152.43%-49.91%562.30%
Return on Assets (ROA)
-153.82%-157.23%-185.44%-112.10%-50.35%-55.57%
Return on Invested Capital (ROIC)
221.65%212.85%299.40%553.81%1031.97%113.90%
Return on Capital Employed (ROCE)
-834.29%-829.38%-510.15%-148.49%-55.38%-676.64%
Earnings Yield
-9.32%-49.72%-32.04%-34.12%-20.07%-14.19%
FCF Yield
--1.99%-0.98%-1.09%-1.28%-0.25%
Buyback Yield / Dilution
--1.38%-1.15%-0.45%-3.79%-0.58%
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q